Works matching IS 17539447 AND DT 2016 AND VI 10 AND IP 3
Results: 7
Renin–angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 172, doi. 10.1177/1753944716648851
- By:
- Publication type:
- Article
Preface.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 116, doi. 10.1177/1753944716645029
- By:
- Publication type:
- Article
Mega clinical trials which have shaped the RAS intervention clinical practice.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 133, doi. 10.1177/1753944716644131
- By:
- Publication type:
- Article
Pharmacological interventions into the renin–angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 151, doi. 10.1177/1753944716644130
- By:
- Publication type:
- Article
Vascular ageing and interventions: lessons and learnings.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 126, doi. 10.1177/1753944716642681
- By:
- Publication type:
- Article
Drug discovery in renin–angiotensin system intervention: past and future.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 118, doi. 10.1177/1753944716642680
- By:
- Publication type:
- Article
Cardiac remodelling and RAS inhibition.
- Published in:
- Therapeutic Advances in Cardiovascular Disease, 2016, v. 10, n. 3, p. 162, doi. 10.1177/1753944716642677
- By:
- Publication type:
- Article